H-Ras-specific upregulation of granulocyte colony-stimulating factor promotes human breast cell invasion via matrix metalloproteinase-2

Cytokine

Volumn 55, Issue 1, 2011, Pages 126-133

  Park, Sunhwa ^a   Kim, Eun Sook ^a   Noh, Dong Young ^b   Hwang, Ki Tae ^c   Moon, Aree ^a  

^a Duksung Women's University   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

Author keywords

Breast cell invasion; G CSF; MMP 2; Ras

Indexed keywords

GELATINASE A; GRANULOCYTE COLONY STIMULATING FACTOR; H RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; RAC1 PROTEIN; RAS PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER INVASION; CELL MIGRATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CELL LINE; CELL MOVEMENT; ENZYME ACTIVATION; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS P21(RAS); RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 79956340285     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.03.002     Document Type: Article

References (34)

1. Clair T., Miller W.R., Cho-Chung Y.S. Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer. Cancer Res 1987, 47:5290-5293.
2. Watson D.M., Elton R.A., Jack W.J., Dixon J.M., Chetty U., Miller W.R. The H-ras oncogene product p21 and prognosis in human breast cancer. Breast Cancer Res Treat 1991, 17:161-169.
3. Moon A., Kim M.S., Kim T.G., Kim S.H., Kim H.E., Chen Y.Q., et al. H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: a role for MMP-2 in the H-ras-induced invasive phenotype. Int J Cancer 2000, 85:176-181.
4. Kim M.S., Lee E.J., Kim H.R., Moon A. P38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res 2003, 63:5454-5461.
5. Moon A., Yong H.Y., Song J.I., Cukovic D., Salagrama S., Kaplan D., et al. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion. Mol Cancer Res 2008, 6:1544-1553.
6. Demetri G.D., Griffin J.D. Granulocyte colony-stimulating factor and its receptor. Blood 1991, 78:2791-2808.
7. American Society of Clinical Oncology Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 1994, 12:2471-2508.
8. Wu F.P., Westphal J.R., Hoekman K., Mels A.K., Statius Muller M.G., de Waal R.W., et al. The effects of surgery, with or without rhGM-CSF, on the angiogenic profile of patients treated for colorectal carcinoma. Cytokine 2004, 25:68-72.
9. Altundag K., Altundag O., Elkiran E.T., Cengiz M., Ozisik Y. Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: interaction of G-CSF with dormant micrometastatic breast cancer cells. Med Hypotheses 2004, 63:56-58.
10. Gutschalk C.M., Herold-Mende C.C., Fusenig N.E., Mueller M.M. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Cancer 2006, 66:8026-8036.
11. Mueller M.M., Herold-Mende C.C., Riede D., Lange M., Steiner H.H., Fusenig N.E. Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression. Am J Pathol 1999, 155:1557-1567.
12. Mueller M.M., Fusenig N.E. Constitutive expression of G-CSF and GM-CSF in human skin carcinoma cells with functional consequence for tumor progression. Int J Cancer 1999, 83:780-789.
13. Pei X.H., Nakanishi Y., Takayama K., Bai F., Hara N. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells. Br J Cancer 1999, 79:40-46.
14. Sherwood D.R. Cell invasion through basement membranes: an anchor of understanding. Trends Cell Biol 2006, 16:250-256. [Review].
15. Stetler-Stevenson W.G., Aznavoorian S., Liotta L.A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993, 9:541-543.
16. Song H., Ki S.H., Kim S.G., Moon A. Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res 2006, 66:10487-10496.
17. Sugimoto C., Fujieda S., Sunaga H., Noda I., Tanaka N., Kimura Y., et al. Granulocyte colony-stimulating factor (G-CSF)-mediated signaling regulates type IV collagenase activity in head and neck cancer cells. Int J Cancer 2001, 93:42-46.
18. Yagima Y., Avigdor A., Goichberg P., Shivtiel S., Tesio M., Kalinkovich A., et al. MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization. J Clin Invest 2009, 119:492-503.
19. Shirvaikar N., Marquez-Curtis L.A., Shaw A.R., Turner A.R., Janowska-Wieczorek A. MT1-MMP association with membrane lipid rafts facilitates G-CSF-induced hematopoietic stem/progenitor cell mobilization. Exp Hematol 2010, [Epub ahead of print].
20. Carstanjen D., Ulbricht N., Iacone A., Regenfus M., Salama A. Matrix metalloproteinase-9 (gelatinase B) is elevated during mobilization of peripheral blood progenitor cells by G-CSF. Transfusion 2002, 42:588-596.
21. Fusté B., Mazzara R., Escolar G., Merino A., Ordinas A., Díaz-Ricart M. Granulocyte colony-stimulating factor increases expression of adhesion receptors on endothelial cells through activation of p38 MAPK. Haematologica 2004, 89:578-585.
22. Wang L., Xue J., Zadorozny E.V., Robinson E.J. G-CSF stimulates Jak2-dependent Gab2 phosphorylation leading to Erk1/2 activation and cell proliferation. Cell Signal 2008, 20:1890-1899.
23. Zhu Q.S., Robinson L.J., Roginskaya V., Corey S.J. G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses. Blood 2004, 103:3305-3312.
24. Makino T., Yamasaki M., Takeno A., Shirakawa M., Miyata H., Takiguchi S. Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus. Br J Cancer 2009, 101:1298-1306.
25. Shin I., Kim S., Song H., Kim H.R., Moon A. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J Biol Chem 2005, 280:14675-14683.
26. Bian J., Sun Y. Transcriptional activation by p53 of the human type IV collagenase gelatinase A or matrix metalloproteinase 2 promoter. Mol Cell Biol 1997, 17:6330-6338.
27. Ma Z., Qin H., Benveniste E.M. Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J Immunol 2001, 167:5150-5159.
28. Moll R., Franke W.W., Schiller D.L., Geiger B., Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982, 31:11-24.
29. Winkler I.G., Lévesque J.P. Mechanisms of hematopoietic stem cell mobilization: when innate immunity assails the cells that make blood and bone. Exp Hematol 2006, 34:996-1009. [Review].
30. Rausch O., Marshall C.J. Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway. Mol Cell Biol 1997, 17:1170-1179.
31. Keely P.J., Westwick J.K., Whitchead I.P., Der C.J., Parise L.Y. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI (3) K. Nature 1997, 390:632-636.
32. Engers R., Springer E., Michiels F., Collard J.G., Gabbert H.E. Rac affects invasion of human renal cell carcinomas by up-regulating tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 expression. J Biol Chem 2001, 276:41889-41897.
33. Lee T.K., Man K., Ho J.W., Wang X.H., Poon R.T., Sun C.K., et al. Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target. Carcinogenesis 2005, 26:681-687.
34. Milsom M.D., Lee A.W., Zheng Y., Cancelas J.A. Fanca-/- hematopoietic stem cells demonstrate a mobilization defect which can be overcome by administration of the Rac inhibitor NSC23766. Haematologica 2009, 94:1011-1015.